Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tirzepatide 5mg/0.6ml inj 2.4ml pf dispos dev
0601023AZAAAGAG
|
Tirzepatide | Tirzepatide | Endocrine System | 35,918 |
|
Tirzepatide 2.5mg/0.6ml inj 2.4ml pf dispos dev
0601023AZAAAHAH
|
Tirzepatide | Tirzepatide | Endocrine System | 19,430 |
|
Tirzepatide 7.5mg/0.6ml inj 2.4ml pf dispos dev
0601023AZAAACAC
|
Tirzepatide | Tirzepatide | Endocrine System | 9,975 |
|
Tirzepatide 10mg/0.6ml inj 2.4ml pf dispos dev
0601023AZAAAFAF
|
Tirzepatide | Tirzepatide | Endocrine System | 5,564 |
|
Tirzepatide 12.5mg/0.6ml inj 2.4ml pf dispos dev
0601023AZAAAEAE
|
Tirzepatide | Tirzepatide | Endocrine System | 1,446 |
|
Tirzepatide 15mg/0.6ml inj 2.4ml pf dispos dev
0601023AZAAADAD
|
Tirzepatide | Tirzepatide | Endocrine System | 1,328 |
|
Tirzepatide 2.5mg/0.5ml inj pre-filled disposable devices
0601023AZAAAAAA
|
Tirzepatide | Tirzepatide | Endocrine System | 28 |
|
Tirzepatide 5mg/0.5ml inj pre-filled disposable devices
0601023AZAAABAB
|
Tirzepatide | Tirzepatide | Endocrine System | 25 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.